Apatinib for Esophageal Squamous Cell Cancer After the Fuailuare of Standard Streatment

Condition:   Esophageal Squamous Cell Carcinoma
Intervention:   Drug: Apatinib Mesylate
Sponsor:   Yuhong Li
Recruiting - verified November 2016

http://ift.tt/2g1GmjV